Home » Pharma Blog Watch
Pharma Blog Watch
Sanofi-Aventis'
Secret ImClone Bid (PharmaGossip)
In this post, an insider blogger discusses a New York Times report that
sanofi-aventis was the company that bid to acquire ImClone Systems. "Shares
of ImClone soared last week after the company announced that Carl C. Icahn,
who holds a stake of nearly 14 percent in the company, had scuttled a potential
takeover offer of $36 a share from a 'major international pharmaceutical company'
last month," the blogger notes.
"The disclosure of a would-be suitor, which ImClone did not identify, became the latest point of contention in an escalating battle between Mr. Icahn and the company."
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct